APA (7th ed.) Citation

Medicines, O. (2026). Orbis Medicines Enters Multi-Target Drug Discovery Partnership with Novo Nordisk Worth up to USD 1.4 Billion. Business Wire (English).

Chicago Style (17th ed.) Citation

Medicines, Orbis. "Orbis Medicines Enters Multi-Target Drug Discovery Partnership with Novo Nordisk Worth Up to USD 1.4 Billion." Business Wire (English) 2026.

MLA (9th ed.) Citation

Medicines, Orbis. "Orbis Medicines Enters Multi-Target Drug Discovery Partnership with Novo Nordisk Worth Up to USD 1.4 Billion." Business Wire (English), 2026.